659MO Preliminary Results from a Phase I/II Study of 9MW2821, an Antibody-Drug Conjugate Targeting Nectin-4, in Patients with Advanced Solid Tumors
Annals of Oncology(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined